Jessica Marie Cahill

Array ( [id] => 20393151 [patent_doc_number] => 20250368626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE [patent_app_type] => utility [patent_app_number] => 19/303585 [patent_app_country] => US [patent_app_date] => 2025-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19303585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20218499 [patent_doc_number] => 20250281430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => BUPROPION AS A MODULATOR OF DRUG ACTIVITY [patent_app_type] => utility [patent_app_number] => 19/219972 [patent_app_country] => US [patent_app_date] => 2025-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19219972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20207246 [patent_doc_number] => 20250276966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives [patent_app_type] => utility [patent_app_number] => 19/210024 [patent_app_country] => US [patent_app_date] => 2025-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87313 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19210024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20621662 [patent_doc_number] => 12589156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (LRRK2) [patent_app_type] => utility [patent_app_number] => 19/088147 [patent_app_country] => US [patent_app_date] => 2025-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39665 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20085036 [patent_doc_number] => 20250214972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => FIVE-MEMBERED-FUSED SIX-MEMBERED COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE [patent_app_type] => utility [patent_app_number] => 19/086136 [patent_app_country] => US [patent_app_date] => 2025-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19086136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20633413 [patent_doc_number] => 12594276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-07 [patent_title] => Inhibitors of human immunodeficiency virus replication [patent_app_type] => utility [patent_app_number] => 19/043910 [patent_app_country] => US [patent_app_date] => 2025-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 119284 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19043910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19977148 [patent_doc_number] => 12344609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-01 [patent_title] => WRN inhibitors [patent_app_type] => utility [patent_app_number] => 19/038532 [patent_app_country] => US [patent_app_date] => 2025-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68256 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19038532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19996672 [patent_doc_number] => 20250134894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => COMPOSITIONS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 19/003405 [patent_app_country] => US [patent_app_date] => 2024-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19003405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20466561 [patent_doc_number] => 12522593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Azacycloalkyl carbonyl cyclic amine compound [patent_app_type] => utility [patent_app_number] => 18/970835 [patent_app_country] => US [patent_app_date] => 2024-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25516 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570214 [patent_doc_number] => 20240374506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS [patent_app_type] => utility [patent_app_number] => 18/732392 [patent_app_country] => US [patent_app_date] => 2024-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19904102 [patent_doc_number] => 12281098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-22 [patent_title] => Five-membered-fused six-membered compound, preparation method, pharmaceutical composition and use [patent_app_type] => utility [patent_app_number] => 18/632351 [patent_app_country] => US [patent_app_date] => 2024-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28239 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18632351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19343549 [patent_doc_number] => 20240252512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4- OXAZEPANE-2-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 18/621023 [patent_app_country] => US [patent_app_date] => 2024-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19586346 [patent_doc_number] => 20240383903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-21 [patent_title] => Modulators of STING (Stimulator of Interferon Genes) [patent_app_type] => utility [patent_app_number] => 18/608816 [patent_app_country] => US [patent_app_date] => 2024-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19389354 [patent_doc_number] => 20240279224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => QUINOLINES AND AZAQUINOLINES AS INHIBITORS OF CD38 [patent_app_type] => utility [patent_app_number] => 18/590300 [patent_app_country] => US [patent_app_date] => 2024-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 873 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19387110 [patent_doc_number] => 20240276980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => ADJUVANT SYSTEMS FOR IMPROVED DELIVERY OF ACTIVE INGREDIENTS USING PULSED SPRAY CROP APPLICATIONS [patent_app_type] => utility [patent_app_number] => 18/581208 [patent_app_country] => US [patent_app_date] => 2024-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18581208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691220 [patent_doc_number] => 20250009765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS FOR REDUCING SLEEP DISTURBANCES AND TREATING SLEEP DISORDERS [patent_app_type] => utility [patent_app_number] => 18/444077 [patent_app_country] => US [patent_app_date] => 2024-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18444077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19331245 [patent_doc_number] => 20240245675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => PROTEIN SECRETION INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/425076 [patent_app_country] => US [patent_app_date] => 2024-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -108 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19387850 [patent_doc_number] => 20240277720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => STABILIZED APILIMOD COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/410608 [patent_app_country] => US [patent_app_date] => 2024-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18410608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19111178 [patent_doc_number] => 20240122928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => Methods For Treating Agitation In Subjects With Mild Cognitive Impairment Or Major Neurocognition Disorder [patent_app_type] => utility [patent_app_number] => 18/529147 [patent_app_country] => US [patent_app_date] => 2023-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19884134 [patent_doc_number] => 12269826 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-08 [patent_title] => 7H-pyrido[4',3':4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors [patent_app_type] => utility [patent_app_number] => 18/511318 [patent_app_country] => US [patent_app_date] => 2023-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9074 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511318 [rel_patent_id] =>[rel_patent_doc_number] =>)